{"disease":{"id":"advanced-solid-tumors-with-homozygous-mtap-deletion","name":"advanced solid tumors with homozygous mtap deletion"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06672523","title":"A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":8,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}